Joint Patient-Level Analysis of Saphenous Vein Graft Occlusion and Bleeding in the TOP-CABG Randomised Trial

Abstract Text Abstract Background Trials after coronary artery bypass grafting commonly report saphenous vein graft occlusion and bleeding separately, obscuring their overlap within participants. Aims To describe the joint patient-level distribution of one-year saphenous vein graft occlusion and clinically relevant bleeding in a randomised trial comparing 12 and 3 months of dual antiplatelet therapy after coronary artery bypass grafting. Methods This secondary analysis aggregated graft observations for each participant with evaluable one-year imaging. Four mutually exclusive categories described neither outcome, graft occlusion without bleeding, bleeding without graft occlusion, and both. Treatment groups were compared using an unadjusted multinomial model. Occlusion burden and analyses addressing missing imaging were examined. Results Among 2,070 participants with evaluable imaging, 71.8% had neither outcome, 17.3% had graft occlusion without bleeding, 8.5% had bleeding without graft occlusion, and 2.3% had both. The distributions were 69.8%, 16.8%, 10.2%, and 3.2% with 12-month dual antiplatelet therapy and 73.9%, 17.8%, 6.8%, and 1.4% with 3-month therapy (global P = 0.00164). Relative to neither outcome, relative risk ratios were 1.00 (95% confidence interval 0.79–1.26), 1.57 (1.14–2.16), and 2.34 (1.26–4.34), respectively. Among 407 participants with any graft occlusion, 287 had one and 120 had multiple occluded grafts. Analyses addressing missing imaging gave similar directional findings. Conclusions Joint patient-level reporting revealed within-participant overlap between graft occlusion and bleeding and added information on graft-occlusion multiplicity to conventional endpoint summaries. Trial registration number: NCT05380063

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11446226/v1
Primary Topic
Cardiac and Coronary Surgery Techniques
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Joint Patient-Level Analysis of Saphenous Vein Graft Occlusion and Bleeding in the TOP-CABG Randomised Trial

Qiduo Chen, Hourong Sun, Donglin Xu, zengkun Liu et al.
Research Square
Cardiac and Coronary Surgery Techniques
preprint

Joint Patient-Level Analysis of Saphenous Vein Graft Occlusion and Bleeding in the TOP-CABG Randomised Trial

Qiduo Chen, Hourong Sun, Donglin Xu, zengkun Liu, Ang Li, Zhen Yu, Jing Liu
preprint en

Abstract

Abstract Text Abstract Background Trials after coronary artery bypass grafting commonly report saphenous vein graft occlusion and bleeding separately, obscuring their overlap within participants. Aims To describe the joint patient-level distribution of one-year saphenous vein graft occlusion and clinically relevant bleeding in a randomised trial comparing 12 and 3 months of dual antiplatelet therapy after coronary artery bypass grafting. Methods This secondary analysis aggregated graft observations for each participant with evaluable one-year imaging. Four mutually exclusive categories described neither outcome, graft occlusion without bleeding, bleeding without graft occlusion, and both. Treatment groups were compared using an unadjusted multinomial model. Occlusion burden and analyses addressing missing imaging were examined. Results Among 2,070 participants with evaluable imaging, 71.8% had neither outcome, 17.3% had graft occlusion without bleeding, 8.5% had bleeding without graft occlusion, and 2.3% had both. The distributions were 69.8%, 16.8%, 10.2%, and 3.2% with 12-month dual antiplatelet therapy and 73.9%, 17.8%, 6.8%, and 1.4% with 3-month therapy (global P = 0.00164). Relative to neither outcome, relative risk ratios were 1.00 (95% confidence interval 0.79–1.26), 1.57 (1.14–2.16), and 2.34 (1.26–4.34), respectively. Among 407 participants with any graft occlusion, 287 had one and 120 had multiple occluded grafts. Analyses addressing missing imaging gave similar directional findings. Conclusions Joint patient-level reporting revealed within-participant overlap between graft occlusion and bleeding and added information on graft-occlusion multiplicity to conventional endpoint summaries. Trial registration number: NCT05380063

Research Square
Qilu Hospital of Shandong University (CN)
Natural Science Foundation of Shandong Province
Good health and well-being
Cardiac and Coronary Surgery Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon